Apoptosis-Regulating Factors in Developing and Adult Ovaries

Apoptosis-Regulating Factors in Developing and Adult Ovaries

D 1080 OULU 2010 D 1080 UNIVERSITY OF OULU P.O.B. 7500 FI-90014 UNIVERSITY OF OULU FINLAND ACTA UNIVERSITATIS OULUENSIS ACTA UNIVERSITATIS OULUENSIS ACTA SERIES EDITORS DMEDICA Minna Jääskeläinen ASCIENTIAE RERUM NATURALIUM Minna Jääskeläinen Professor Mikko Siponen APOPTOSIS-REGULATING BHUMANIORA FACTORS IN DEVELOPING University Lecturer Elise Kärkkäinen CTECHNICA AND ADULT OVARIES Professor Hannu Heusala DMEDICA Professor Olli Vuolteenaho ESCIENTIAE RERUM SOCIALIUM Senior Researcher Eila Estola FSCRIPTA ACADEMICA Information officer Tiina Pistokoski GOECONOMICA University Lecturer Seppo Eriksson EDITOR IN CHIEF Professor Olli Vuolteenaho PUBLICATIONS EDITOR Publications Editor Kirsti Nurkkala UNIVERSITY OF OULU, FACULTY OF MEDICINE, INSTITUTE OF CLINICAL MEDICINE, ISBN 978-951-42-6346-0 (Paperback) DEPARTMENT OF OBSTETRICS AND GYNECOLOGY; ISBN 978-951-42-6347-7 (PDF) OULU UNIVERSITY HOSPITAL, ISSN 0355-3221 (Print) CLINICAL RESEARCH CENTER ISSN 1796-2234 (Online) ACTA UNIVERSITATIS OULUENSIS D Medica 1080 MINNA JÄÄSKELÄINEN APOPTOSIS-REGULATING FACTORS IN DEVELOPING AND ADULT OVARIES Academic dissertation to be presented with the assent of the Faculty of Medicine of the University of Oulu for public defence in Auditorium 4 of Oulu University Hospital, on 26 November 2010, at 12 noon UNIVERSITY OF OULU, OULU 2010 Copyright © 2010 Acta Univ. Oul. D 1080, 2010 Supervised by Doctor Tommi Vaskivuo Professor Juha Tapananainen Reviewed by Professor Sari Mäkelä Professor Olli Ritvos ISBN 978-951-42-6346-0 (Paperback) ISBN 978-951-42-6347-7 (PDF) http://herkules.oulu.fi/isbn9789514263477/ ISSN 0355-3221 (Printed) ISSN 1796-2234 (Online) http://herkules.oulu.fi/issn03553221/ Cover Design Raimo Ahonen JUVENES PRINT TAMPERE 2010 Jääskeläinen, Minna, Apoptosis-regulating factors in developing and adult ovaries University of Oulu, Faculty of Medicine, Institute of Clinical Medicine, Department of Obstetrics and Gynecology, P.O.Box 5000, FI-90014 University of Oulu, Finland; Oulu University Hospital, Clinical Research Center, P.O. Box 5000, FI-90014 University of Oulu, Finland Acta Univ. Oul. D 1080, 2010 Oulu, Finland Abstract Apoptosis plays a crucial part in human ovarian function from fetal development to the end of reproductive potential. Failures in the regulation of ovarian apoptosis are associated with many pathological conditions such as premature ovarian insufficiency, infertility and cancer. The purpose of the present study was to analyze the factors regulating cell survival in human fetal and adult ovaries. The fetus is exposed to maternal- and placental-derived estrogens and insufficient estrogen action has destructive effects on rodent ovarian development. We detected estrogen receptors and estrogen-converting enzymes in human fetal ovaries after primordial follicle formation, indicating that estrogens participate in human fetal ovarian development, especially after folliculogenesis. The WNT4 gene is crucial for female sexual differentiation, follicle formation and oocyte survival. We detected WNT4 in follicular cells of fetal and adult human ovaries. In addition, Wnt4- knockout mice demonstrated a dramatic loss of oocytes before birth. However, no changes were detected in protein expression patterns of common apoptosis-related proteins. The results support the possible role of WNT4 in human ovarian function and strengthen previous knowledge on the antiapoptotic role of Wnt4. Apoptosis signaling is mediated by extracellular- and mitochondria-associated- pathways, ending in caspase cascade activation and fragmentation of cellular structures. In the present study we analyzed the expression of several apoptosis-related factors and detected TRAIL, TNF, Bcl- XL, Bok and caspase-3 in human ovaries. In addition, TRAIL was found to be a potent and rapid inducer of human granulosa tumor cell (KGN) apoptosis. Lentiviral downregulation of Bok or Bcl-XL protein expression in KGN cells also resulted in significant changes in cell vulnerability to apoptosis. The results show for the first time the spatiotemporal expression patterns of TRAIL, TNF, Bcl-XL, Bok and caspase-3 in human ovaries and suggest an important functional role of TRAIL, Bok and Bcl-XL in regulation of human ovarian apoptosis. The present study offers novel information on the expression and function of cell survival factors in human ovaries. These new findings open possibilities for future clinical research in attempts to understand and treat ovarian diseases caused by imbalanced regulatory pathways of apoptosis. Keywords: TNF-related apoptosis-inducing ligand, Wnt proteins, apoptosis, caspase 3, estrogens, granulosa cells, oocytes, ovary, proto-oncogen proteins c-Bcl-2, tumor necrosis factor- alpha To my father 6 Aknowledgements This study was carried out at the Department of Obstetrics & Gynecology, Universtity of Oulu and at the Clinical Research Center, Oulu University Hospital during the years 2003–2010. I am deeply grateful to my supervisors, Prof. Juha Tapanainen and Ph.D. Tommi Vaskivuo for introducing me to the interesting research topic of ovarian apoptosis and for providing me with the possibility to carry out my research in a well-guided group utilizing modern laboratory facilities. Tommi Vaskivuo´s excellent knowledge of the complex pathways of apoptosis and his guiding hand in laboratory techniques have been irreplaceable. I also want to thank Tommi for teaching me the basics of scientific writing. I owe additional gratitude to Prof. Tapanainen, who has had a crucial role in my thesis work. Without his expert guidance and encouraging attitude this work would never have been finished. I have had the privilege to work in a high quality research group with wonderful colleagues. I thank Reeta Pökkylä, Johanna Puurunen, Sanna Kallio, Kristiina Ahokas, Mervi Haapsamo, Outi Uimari and Zdravka Veleva for their support and many enjoyable moments in the office, lab and sauna. Terhi Piltonen, Laure Morin-Papunen, Hannu Martikainen and Jouni Lakkakorpi are thanked for having the time and enthusiasm to participate in our research meetings and for adding many valuable and supportive comments. I am grateful to Prof. Markku Heikinheimo and Prof. Seppo Vainio for their professional advices when planning and carrying out the laboratory work and writing the articles and thesis. I thank prof. Sari Mäkelä and prof. Olli Ritvos for their careful review of the thesis. Mirja Ahvensalmi is acknowledged for her skilful laboratory assistance. I owe my gratitude also to Seija Leskelä whose expertise in figure editing has made it possible to create high quality figures in all of my publications. It has been a joy to work with Seija and I trust that our friendship will continue in the future. Special thanks go to my dearest friends Anna Toppari, Sanna Kaijalainen, Hanna Ikonen, Petra Marttila, Sara Holopainen and Miia Hernetkoski. Their support and company over the years have been very important to me. The members of NNA will always be a part of my heart! I also wish to thank Tiia Kangas-Kontio for her warm friendship and everlasting belief in our mutual projects at work and at home. My dear colleagues and friends Erja Mustonen, Marja Majava, Maria Haanpää and Heini Savolainen are thanked for being there 7 for me in the moments of joy and desperation. I have really enjoyed our long- lasting conversations and cooking, baking and studying together. My beloved father Olli Mäentausta needs to be thanked for getting me interested in doing research. His enthusiasm and interest towards my work has been my most important source of motivation and I have been following his footsteps with great honor. I also wish to thank my loving mother Tiina Tervaskanto-Mäentausta and my sisters Tuuli, Meri, Salla and brother Antti for love and support. I owe my warmest thanks to my husband Jari and our little sunshine Miisa– you mean the world to me! This study was financially supported by the Academy of Finland, the Sigrid Jusélius Foundation, Oulu University Hospital, Gynekologisen Tutkimuksen rahasto, Universtity of Oulu, Tyyni Tani Foundation, Suomen Lääketieteen Säätiö, Norjalais-Suomalainen Lääketieteen Säätiö and Suomen Gynekologiyhdistys. Oulu, September 2010 Minna Jääskeläinen 8 Abbreviations Apaf-1 Apoptosis protease activating factor-1 Bax Bcl-2-associated x protein Bcl-2 B cell leukemia-2 Bcl-XL B cell leukemia-x long bFGF Basic fibroblast growth factor BH Bcl-2 homology Bmp-2 Bone morphogenic protein 2 Bok Bcl-2 related ovarian killer cDNA Complementary DNA cpm Counts per minute DAB Diamino benzidine dpc Days post coitum EGF Epidermal growth factor ER Estrogen receptor ERKO Estrogen receptor knockout FAS-L FAS-ligand FSH Follicle-stimulating hormone Fst Follistatin GDF-9 Growth differentiation factor-9 GnRH Gonadotropin-releasing hormone hCG Human chorionic gonadotropin HSD17B Hydroxysteroid (17B) dehydrogenase IGF-1 Insulin-like growth factor-1 Inhbb Inhibin β B LH Luteinizing hormone PBS Phosphate-buffered saline RNA Ribonucleic acid RSPO1 R-spondin homolog 1 STS Staurosporine TGFα Transforming growth factor α TNF Tumor necrosis factor TRAIL Tumour necrosis factor-related apoptosis-inducing ligand WNT4 Wingless type MMTV family member 4 9 10 List of original publications The thesis is based on the following articles, which are referred in the text by their Roman numerals: I Vaskivuo TE, Mäentausta M, Torn S, Oduwole O, Lönnberg A, Herva R, Isomaa V & Tapanainen JS (2005) Estrogen receptors and estrogen-metabolizing enzymes in human ovaries during fetal development. J Clin Endocrinol Metab

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    100 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us